IntegraGen Logo

IntegraGen

Provides genomic services for cancer and rare diseases, translating research to practice.

ALINT | PA

Overview

Corporate Details

ISIN(s):
FR0010908723
LEI:
969500CQD8K0BUIGDH55
Country:
France
Address:
5 RUE HENRI DESBRUERES, 91000 EVRY-COURCOURONNES

Description

IntegraGen, an OncoDNA company, specializes in translating molecular research into clinical practice, with a primary focus on cancer genomics and rare genetic diseases. The company provides comprehensive genomic services, including Next-Generation Sequencing (NGS) and advanced bioinformatics analysis, to academic researchers, biopharmaceutical companies, and clinical research organizations. Operating from a CLIA/CAP-certified laboratory, IntegraGen is a key genomics partner for oncology clinical trials. Its core mission involves identifying novel genetic biomarkers to develop and commercialize molecular diagnostic tests, delivering interpretable genomic data to advance both research and patient care.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2019-04-18 07:30
Informations privilégiées / Communiqué sur comptes, résultats
French 307.5 KB
2019-03-05 07:30
Communiqués au titre de l'obligation d'information permanente / Autres communiq…
French 699.9 KB
2019-01-15 18:00
Rachat d'actions / Contrat de liquidité Information relative au contrat de liqu…
French 195.9 KB
2019-01-09 18:00
Communiqués au titre de l'obligation d'information permanente / Information sur…
French 262.4 KB
2018-06-06 18:00
Information relative au nombre total de droits de vote et d'actions composant l…
French 197.7 KB
2018-05-02 18:16
Information relative au nombre total de droits de vote et d'actions composant l…
French 385.0 KB
2018-04-26 18:00
Communiqués de mise à disposition de documents / Modalités de mise à dispositio…
French 252.2 KB
2018-04-26 18:00
Rapport financier annuel
French 5.3 MB
2018-04-23 17:45
Communicated under the obligation to provide permanent information / Other comm…
English 382.3 KB
2018-04-23 17:45
Communiqués au titre de l'obligation d'information permanente / Autres communiq…
French 477.6 KB
2018-04-12 08:00
Communicated under the obligation to provide permanent information / Other comm…
English 241.2 KB
2018-04-12 08:00
Communiqués au titre de l'obligation d'information permanente / Autres communiq…
French 557.9 KB
2018-04-03 18:00
Information relative au nombre total de droits de vote et d'actions composant l…
French 387.4 KB
2018-03-01 18:00
Information relative au nombre total de droits de vote et d'actions composant l…
French 387.6 KB
2018-02-14 08:30
Communiqués au titre de l'obligation d'information permanente / Activité de l'é…
French 606.9 KB

Automate Your Workflow. Get a real-time feed of all IntegraGen filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IntegraGen

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IntegraGen via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.